In Vitro Activity of Tigecycline against Staphylococcus epidermidis Growing in an Adherent-Cell Biofilm Model

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 12, 2003, Pages 3967-3969

  Labthavikul, Pornpen ^a   Petersen, Peter J ^a,b   Bradford, Patricia A ^a  

^a Wyeth   (United States)

^b WYETH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AC 98 6446; ANTIINFECTIVE AGENT; CEFAZOLIN; CIPROFLOXACIN; COTRIMOXAZOLE; DAPTOMYCIN; GENTAMICIN; MINOCYCLINE; OXACILLIN; RIFAMPICIN; TEICOPLANIN; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BACTERIUM COLONY; BACTERIUM ISOLATE; BIOFILM; CONCENTRATION RESPONSE; IN VITRO STUDY; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROCESS MODEL; STAPHYLOCOCCUS EPIDERMIDIS;

BACTERIAL ADHESION; BIOFILMS; COLONY COUNT, MICROBIAL; CULTURE MEDIA; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; POLYSACCHARIDES; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0344443190     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.12.3967-3969.2003     Document Type: Article

References (17)

1. Biedenbach, D. J., M. L. Beach, and R. N. Jones. 2001. In vitro antimicrobial activity of GAR-936 tested against antibiotic resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases. Diagn. Microbiol. Infect. Dis. 40:173-177.
2. Brown, M. R., D. G. Allison, and P. Gilbert. 1988. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J. Antimicrob. Chemother. 22:777-780.
3. Christensen, G. D., W. A. Simpson, J. J. Younger, L. M. Baddour, F. F. Barrett, D. M. Melton, and E. H. Beachey. 1985. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22:996-1006.
4. Danese, P. N. 2002. Antibiofilm approaches: prevention of catheter colonization. Chem. Biol. 9:873-880.
5. Drancourt, M., A. Stein, J. N. Argenson, A. Zannier, G. Curvale, and D. Raoult. 1993. Oral rifampin plus of loxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob. Agents Chemother. 37:1214-1218.
6. Evans, R. C., and C. J. Holmes. 1987. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob. Agents Chemother. 31:889-894.
7. Gales, A. C., and R. N. Jones. 2000. Antimicrobial activity and spectrum of the new glycylcycline GAR-936 tested against 1,203 recent clinical isolates. Diagn. Microbiol. Infect. Dis. 36:19-36.
8. Gilbert, P., P. J. Collier, and M. R. Brown. 1990. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob. Agents Chemother. 34:1865-1868.
9. Holme, C. J., and R. C. Evans. 1989. Resistance of bacterial biofilms to antibiotics. J. Antimicrob. Chemother. 24:84-93.
10. Lewis, K. 2001. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45:999-1007.
11. NCCLS. 1999. Methods for determining bactericidal activity of antimicrobial agents, vol. 19. Approved guideline M26-A, NCCLS, Wayne, Pa.
12. NCCLS. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed., vol. 20. Approved standard M7A5. NCCLS, Wayne, Pa.
13. Petersen, P. J., N. V. Jacobus, W. J. Weiss, P. E. Sum, and R. T. Testa. 1999. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43:738-744.
14. Petersen, P. J., P. A. Bradford, W. J. Weiss, T. M. Murphy, P. E. Sum, and S. J. Projan. 2002. In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens. Antimicrob. Agents Chemother. 46:2595-2601.
15. Souli, M., and H. Giamarellou. 1998. Effect of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents. Antimicrob. Agents Chemother. 42:939-941.
16. Trafny, E. A. 1998. Susceptibility of adherent organisms from Pseudomonas aeruginosa and Staphylococcus aureus strains isolated from burn wounds to antimicrobial agents. Int. J. Antimicrob. Agents 10:223-228.
17. Yasuda, H., Y. Ajiki, T. Koga, and T. Yokota. 1994. Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. Antimicrob. Agents Chemother. 38:138-141.